drsanjaypopat.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

Please do check out Roxane Chen’s (my iBSc student - a medical student) poster on pan-immune inflammation scoring and outcomes in ALK positive lung cancer. She worked so hard, and has been rewarded with the first abstract in the book, so no excuses not to engage, people! ❤️ No 1!! 🏅 #BTOG25

submitted 23 hours ago • 1 comment

Fantastic over of #radiation induced pneumonitis by #ESTRO President @mguckenberger.bsky.social at #BTOG25 Updates the congress on the new #ESTRO guidelines in this area @drjnaidoo.bsky.social @drpeedell.bsky.social

submitted 20 hours ago • 0 comments

Can I strongly recommend finebind.co.uk/printing at Belfast Uni who have saved my skin & printed & delivered my #BTOG25 poster within 4hrs for a bargain price of £25! My london printer promised next day delivery on Thursday & failed! #LoveBelfast

submitted 17 hours ago • 0 comments

In 2018, with Tom Newsom-Davis, I wrote a chapter on novel immune check point targets for the ACP book ‘Problem Solving In Cancer Immunotherapy’. It’s fab to sit here and know my research wasn’t too far off and these targets now have drugs! Shobhit Baijal on ‘beyond PDL1/PD1 #BTOG25

submitted 17 hours ago • 0 comments

And that wraps up the afternoon sessions! Don’t forget to check out the exhibition and posters as you grab a refreshment. We will see you again at 16.30 for the last session of the day, the BTOG Welcome and Updates. #BTOG25

submitted 16 hours ago • 0 comments

Huge number of posters accepted. Been wandering round and not sure how only 5 were picked for presentation tomorrow, some great work! #BTOG25

submitted 15 hours ago • 0 comments

Fascinating insights

submitted 7 hours ago • 0 comments

En route to #BTOG25? The team are ready! Looking forward to seeing you there. Do say “hello” when you catch me! It will be an awesome meeting! @btog.bsky.social

submitted 1 day ago • 0 comments

#PubMed is down: a disaster for medicine and healthcare globally. It’s a critical tool to find medical data. I sincerely hope this is a temporary technical glitch and not reflective of the political change ongoing in the US.

submitted 1 day ago • 4 comments

ALK+ UK is off to @btog.bsky.social next week - a key event in #lungcancer - Debra Montague (Chair) & Geoff Otterman (Treasurer) are attending. We’re delighted to have 2 abstracts accepted for presentation. Looking forward to learning, connecting, & sharing patient perspectives. #BTOG25 #LCSM

submitted 6 days ago • 1 comment

Traveling to #BTOG25 today? Great thread from @tnewsomdavis.bsky.social on what you’ll experience. Get ready!

submitted 1 day ago • 0 comments

A very cool thing about getting older in medicine: eventually you see a dreaded disease of your early career succumb to science. Once you witness it a few times, nothing will seem impossible to you in the same way ever again. #MedSky #DrugDevelopment

submitted 5 days ago • 7 comments

Our new piece in The Lancet on the potential of AI agents in medicine www.thelancet.com/journals/lan... @jameszou.bsky.social

submitted 25 days ago • 2 comments

🔥 @nature.com 🆙 ✅Intrinsic electrical activity drives small-cell lung cancer progression 🎯Cancer cell-intrinsic electrical activity confers long-term tumorigenic capability and metastatic potential 👥Dr. Paola Peinado #LCSM @oncoalert.bsky.social www.nature.com/articles/s41...

submitted 13 days ago • 0 comments

Phenomenal data and unique insights from @charlesswanton.bsky.social and colleagues. Bravo!

submitted 12 days ago • 0 comments

I love @btog.bsky.social I am absolutely NOT telling Mr11 though… he has school!!! Small things help break down barriers for working parents! Kudos!

submitted 40 days ago • 0 comments

What a great welcome to the @btog.bsky.social Stage 4 day!

submitted 31 days ago • 0 comments

Great to see this report from UKRI published today. It contains some concrete proposals for reversing the decline in UK clinical academia. Now they just need to be delivered! www.ukri.org/wp-content/u...

submitted 32 days ago • 1 comment

Passionate about cancer trials, patient-reported outcomes (PROs) & innovative methods? Join the Early Phase and Adaptive Trials Group at @icr-ctsu.bsky.social @icrlondon.bsky.social for an exciting undergraduate summer scholarship in early phase trials & PROs! Deadline: 26/01/25 shorturl.at/1h565

submitted 44 days ago • 0 comments

This is going to be an awesome event. Looking forward to speaking, hearing from my fellow expert colleagues and engaging with the audience @btog.bsky.social

submitted 32 days ago • 0 comments

Agree!

submitted 32 days ago • 0 comments

It is worth remembering the times when 🇬🇧 had vastly inferior drug access compared to 🇪🇺 and 🇺🇸 Now, with only a couple of exceptions, we have everything BTOG, working with NICE & advocating for patients, is one reason for this @btog.bsky.social

submitted 71 days ago • 0 comments

Amazing to see recent NICE approvals: 1. Neoadjuvant alone (CM816): all PDL1 2. Perioperative (KN671, AGEAN) : all PDL1 3. Adjuvant (IMP010, TPS 50+; KN091 all PDL1) 4. Adjuvant EGFRm (ADAURA) 5. Adjuvant ALK+ (ALINA) Biomarker testing in early #NSCLC now critical!

submitted 72 days ago • 1 comment

Thanks, Dr. Eric Singhi @lungoncdoc.bsky.social, for putting together this compilation of all the 2024 FDA #lungcancer approvals! Progress is real! #LCSM

submitted 83 days ago • 2 comments

Details on uncommon #EGFR mutations @jtoonline.bsky.social. In 5212 #EGFR NSCLC dataset, 8.9% were uncommon mutations: associated with smoking history, higher rates of EGFR amp and TP53 co-mt, shorter time on TKI (4.1m) vs common (10.9m). #LCSM #OncSky www.jto.org/article/S155...

submitted 76 days ago • 0 comments

Full house for @BTOGORG Mesothelioma Essential Update 2024 @DrRiyazShah in charge Fantastic energy & enthusiasm for a bright December morning Looking forward to a day of education and networking 👊

submitted 84 days ago • 1 comment

Interesting conclusions from Matthew Tate of the Scottish Mesothelioma Network #mesoupdate24 #mesothelioma

submitted 84 days ago • 0 comments

Improve your mesothelioma service by forming a network: the 🏴󠁧󠁢󠁳󠁣󠁴󠁿 experience by Matthew Tate 🟢 ⬆️ data completeness 🟢 ⬇️ non-biopsy cases 🟢 ⬆️ OS in non-epithelioid 🔺 OS benefit not solely due to arrival of immunotherapy @btog.bsky.social @mesouk.bsky.social

submitted 84 days ago • 0 comments

#mesoupdate24

submitted 84 days ago • 0 comments

Great to hear @drsanjaypopat.bsky.social Having worked in the UK, I know how strict NICE can be. Against that we still have to wait here 🇮🇹 ! I do feel that the paradigm for early-stage ICIs approvals needs to evolve—if I were a patient, I’d want to live a longer life, but possibly disease-free!

submitted 85 days ago • 0 comments

Great to see AGEAN regime approved and reimbursed in England. You know we really are lucky to have this option alongside CM816 & KN671, without PD-L1 restriction

submitted 87 days ago • 0 comments

Was that a collective sigh of relief, I heard?

submitted 89 days ago • 0 comments

Am so lucky to have these 3 amazing and dynamic experts joining the @btog.bsky.social Board of Trustees. Great times ahead.

submitted 89 days ago • 0 comments

Pies or donuts: what’s your favourite?

submitted 91 days ago • 0 comments

A strategic position statement in @Annals_Oncology on the main actions to boost #lungcancer research and innovation: ✅ Pragmatic trials ✅ Ensure inclusivity and diversity ✅ NGS in resectable #NSCLC ✅ Exploit resistance mech ✅Focus on novel Tox bit.ly/4ga8LlC #LCSM #some @iaslc.bsky.social

submitted 92 days ago • 0 comments

Our #AllYouNeedIsLungs 2024 campaign was seen over 1/2 million times – thanks to our 26 incredible ‘voices’ sharing their stories. If you’re living with mutation-driven #lungcancer, & you’d like to share your story for 2025, register interest 👉 allyouneedislungs.org.uk/2025-volunte... #LCSM

submitted 91 days ago • 0 comments

Great to see @drsanjaypopat.bsky.social on #BlueSky. An absolutely essential follow if you have an interest in lung/thoracic cancers. #medonc #radonc #lcsm #mesothelioma #thymoma #MedSky

submitted 92 days ago • 0 comments

Welcome, friend! #LCSM

submitted 93 days ago • 0 comments

Howdy, folks! I've arrived! #LCSM @n8pennell.bsky.social @antoniopassaro.bsky.social @stephenvliu.bsky.social

submitted 93 days ago • 7 comments